Considering the complexity of the pathogenesis of UC and the characteristics of UC prolongation and refractory healing, providing patients with a personalized treatment plan is necessary
cohort of patients with diabetic MASLD, GLP-1a use, when compared with oGLD, was associated with a duration-dependent lower risk of liver and non-liver complications
With the potential for substantial weight reduction and improved glycemic control, GLP-1 therapy provides a comprehensive solution for patients struggling with obesity and type 2 diabetes
SAN DIEGO Structured de-escalation of GLP-1 receptor agonists may lead to sustained health benefits while reducing treatment burden, according to data shown at the Obesity Medicine Associations annual conference
Retatrutide demonstrated 24% weight loss at 48 weeks in Phase 2 trials
To answer your closing question: the speed of expansion in Indian CDMOs will only succeed if the upstream supply chain holds up